Dr. Dana Krämer
studied Biochemistry/Molecular Biology at the University of Jena and finished her undergraduate studies in September 2000 with a diploma thesis on inhibitors of Flt3 tyrosine kinase activity. For her PhD thesis Dr. Krämer joined the Department of Pharmacology of the University of Cambridge, UK where she studied calcium- and calcineurin-dependent gene expression in neuronal cells. From 2004 till 2006, Dr. Krämer held a Postdoctoral Research Fellowship at the Mouse Biology Unit of the European Molecular Biology Laboratory (EMBL) in Monterotondo (Rome, Italy), where she focused on the role of the mRNA binding protein IMP2 in the central nervous system.
Dr. Krämer joined Vossius & Partner in 2006. She was admitted to practice as a European Patent Attorney in 2010 and as a German Patent Attorney in 2016.